Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAXOL for Ovarian cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where TAXOL was used for Ovarian cancer.

Most Reported Side Effects for TAXOL

Side Effect Reports % Deaths Hosp.
Breast cancer 66 35.7% 65 0
Disease progression 21 11.4% 2 2
Pyrexia 10 5.4% 0 8
Dehydration 9 4.9% 3 8
Nausea 9 4.9% 1 5
Dyspnoea 8 4.3% 0 4
Anaemia 7 3.8% 1 4
Diarrhoea 7 3.8% 0 4
Lung infiltration 7 3.8% 0 1
Metastases to bone 7 3.8% 0 1
Metastases to liver 7 3.8% 0 0
Myalgia 7 3.8% 0 5
Neuropathy peripheral 7 3.8% 0 1
Pleural effusion 7 3.8% 0 0
Nervous system disorder 6 3.2% 0 0

Other Indications for TAXOL

Breast cancer (82) Product used for unknown indication (21) Breast cancer metastatic (12)

Other Drugs Used for Ovarian cancer

NIRAPARIB (14,750) RUCAPARIB CAMSYLATE (6,318) OLAPARIB (5,923) CARBOPLATIN (5,850) BEVACIZUMAB (5,283) PACLITAXEL (4,631) DOXORUBICIN (1,692) GEMCITABINE (648) CISPLATIN (555) ATEZOLIZUMAB (519)

Related Pages

TAXOL Full Profile All Ovarian cancer Drugs TAXOL Demographics TAXOL Timeline